IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

FRACANZANI, ANNA LUDOVICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.286
NA - Nord America 12.915
AS - Asia 8.237
SA - Sud America 676
AF - Africa 115
OC - Oceania 68
Continente sconosciuto - Info sul continente non disponibili 19
Totale 43.316
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.508
GB - Regno Unito 9.072
CN - Cina 3.422
IT - Italia 3.356
DE - Germania 2.530
SE - Svezia 1.848
SG - Singapore 1.737
RU - Federazione Russa 1.295
TR - Turchia 678
IN - India 593
UA - Ucraina 571
IE - Irlanda 567
KR - Corea 546
BR - Brasile 452
FR - Francia 447
NL - Olanda 410
FI - Finlandia 362
CA - Canada 328
HK - Hong Kong 305
EU - Europa 266
PL - Polonia 218
ID - Indonesia 196
VN - Vietnam 171
JP - Giappone 155
CO - Colombia 144
DK - Danimarca 144
BE - Belgio 87
TW - Taiwan 79
CH - Svizzera 72
AU - Australia 60
IR - Iran 59
ES - Italia 58
GR - Grecia 58
MX - Messico 53
AT - Austria 44
EG - Egitto 42
RO - Romania 36
UZ - Uzbekistan 25
MY - Malesia 24
AR - Argentina 23
PH - Filippine 23
IL - Israele 22
ZA - Sudafrica 20
CL - Cile 19
IQ - Iraq 19
TH - Thailandia 19
BD - Bangladesh 18
MO - Macao, regione amministrativa speciale della Cina 16
NO - Norvegia 15
PK - Pakistan 15
AE - Emirati Arabi Uniti 14
CZ - Repubblica Ceca 14
RS - Serbia 13
AZ - Azerbaigian 12
PT - Portogallo 12
EC - Ecuador 10
VE - Venezuela 10
DZ - Algeria 9
HU - Ungheria 9
JO - Giordania 9
KE - Kenya 9
LK - Sri Lanka 9
SA - Arabia Saudita 9
SI - Slovenia 9
KZ - Kazakistan 8
NP - Nepal 8
NZ - Nuova Zelanda 8
SC - Seychelles 8
AM - Armenia 7
KG - Kirghizistan 7
PE - Perù 7
TN - Tunisia 7
BO - Bolivia 6
EE - Estonia 6
GE - Georgia 6
PA - Panama 6
PR - Porto Rico 6
SY - Repubblica araba siriana 6
A2 - ???statistics.table.value.countryCode.A2??? 5
LV - Lettonia 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
LT - Lituania 4
MA - Marocco 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
CR - Costa Rica 3
HR - Croazia 3
JM - Giamaica 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
MD - Moldavia 3
MU - Mauritius 3
PY - Paraguay 3
SN - Senegal 3
CI - Costa d'Avorio 2
CM - Camerun 2
CU - Cuba 2
CY - Cipro 2
Totale 43.543
Salva come PNG Salva come JPEG
Città #
Southend 8.672
Houston 1.556
Chandler 1.385
Milan 1.258
Singapore 1.192
Seattle 787
Princeton 664
Beijing 600
Ashburn 574
Wilmington 574
Dublin 556
Frankfurt am Main 482
Fairfield 468
Council Bluffs 442
Jacksonville 441
Dearborn 410
Ann Arbor 395
Hanover 394
Nanjing 339
Woodbridge 274
Redmond 268
Santa Clara 261
Toronto 260
Mountain View 230
Des Moines 217
Hong Kong 210
Bengaluru 207
Munich 202
Warsaw 202
Andover 197
Shanghai 196
Sakarya 189
Boardman 177
Serra 174
Cambridge 165
Somerville 136
Bogotá 135
Jakarta 130
Grafing 127
Phoenix 120
Jinan 113
Helsinki 109
Guangzhou 106
Eitensheim 105
Redwood City 99
Shenyang 99
Istanbul 90
Nanchang 90
Berlin 88
Hangzhou 88
Fuzhou 87
New York 79
Saint Petersburg 79
Hebei 73
Los Angeles 73
Dong Ket 71
Changsha 70
Rome 67
Tianjin 67
Brussels 64
Pisa 57
Turin 55
Bitonto 52
Nuremberg 51
São Paulo 51
Chicago 48
Wuhan 48
Jiaxing 46
London 45
Fremont 43
Chengdu 39
Seoul 39
Taipei 39
Athens 38
San Diego 38
Falls Church 37
Kunming 36
Zhengzhou 36
Quanzhou 34
Genoa 33
Ningbo 33
Tokyo 30
Piscataway 28
Silver Spring 28
Hefei 27
Kent 27
Hamburg 26
Lanzhou 26
Sunnyvale 25
Taizhou 25
Verona 25
Nürnberg 24
Odernheim 24
Vienna 24
Auburn Hills 23
Palermo 23
Central District 22
New Delhi 21
Florence 20
Rho 20
Totale 28.349
Salva come PNG Salva come JPEG
Nome #
Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic Fatty liver disease 1.551
Mapping the human genetic architecture of COVID-19 626
A second update on mapping the human genetic architecture of COVID-19 526
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system 521
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 435
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis 390
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 340
PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma 336
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis 324
The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation 324
Frontline antiviral therapy in a series of HCV-related low grade non-Hodgkin lymphoma 271
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 257
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study 256
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression : An Observational Study in Patients with Nonalcoholic Fatty Liver Disease 253
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease 247
High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload 230
Epicardial Adipose Tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease 228
MAFLD in COVID-19 patients: an insidious enemy 227
The A736V TMPRSS6 Polymorphism Influences Hepatic Iron Overload in Nonalcoholic Fatty Liver Disease 226
Risk of NASH and severe fibrosis in patients with NAFLD and low visceral adiposity 222
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 222
β-Klotho gene variation is associated with liver damage in children with NAFLD 219
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 218
Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease 212
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 208
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 206
Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study 206
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease 205
Response of an Italian reference institute to research challenges regarding a new pandemic: COVID-19 network 204
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis 201
Carotid artery intima-media thickness in nonalcoholic fatty liver disease 197
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 196
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 195
Vascular damage in patients with nonalcoholic fatty liver disease : Possible role of iron and ferritin 194
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease 193
The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls 193
α1-Antitrypsin mutations in NAFLD : high prevalence and association with altered iron metabolism but not with liver damage 192
Variables significantly associated with non alcoholic steatohepatitis (NASH) and fibrosis in patients with non alcoholic fatty liver disease (NAFLD) 192
Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations 189
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage 189
Liver fat accumulation is associated with circulating PCSK9 levels 187
MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD 185
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models 185
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 183
Cell-free DNA in HCV-related cirrhosis and small hepatocellular carcinoma 182
Risk of early atherosclerosis evaluated by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease : a case control study 181
The hand arthropathy of hereditary hemochromatosis is strongly associated with iron overload 181
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 181
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 180
Cell-free DNA in HCV-related cirrhosis and small hepatocellular carcinoma 179
Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study 175
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 174
Searching for coeliac disease in patients with non-alcoholic fatty liver disease 172
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with non-alcoholic fatty live 172
PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease 172
TRB3 is associated with hepatic lipogenesis and dyslipidemia in NAFLD 171
Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis 171
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 170
Increased circulating adiponectin in males with chronic HCV hepatitis 170
Acquired hepatocerebral degeneration (AHD) : a peculiar neurological impairment in advanced chronic liver disease 170
Serum ferritin, is associated with iron availability, decreased anti-oxidant potemtial and HFE gene mutations, and a risk factor for cardiovascular damage in hemodialysis patients 167
Progression of carotic atherosclerotic damage is related to alt values in patients with non alcoholic fatty liver disease 167
Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up 167
Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance 166
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis 165
Aberrant methylation of oncosuppressor genes detected in the peripheral blood of patients with chronic hepatitis C and hepatocellular carcinoma 165
PNPLA3 I148M polymorphism, etiology, and clinical features of hepatocellular carcinoma 165
Effect of iron depletion by phlebotomy on insulin resistance in patients with non alcoholic fatty liver disease and hyperferritinemia : evidence from a case control study 163
Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes : evidence in NAFLD patients and cell cultures 163
Evaluation of three “beyond Baveno VI” criteria to safely spare endoscopies in compensated advanced chronic liver disease 162
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients 162
Increased ferritin predicts vascular damage in patients with nonalcoholic fatty liver disease 161
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C 161
The hand arthropathy of hereditary hemochromatosis is strongly associated with iron overload 160
Association between heterozygosity for HFE gene mutations and hepatis viruses in hepatocellular carcinoma 160
Echocardiographic epicardial fat thickness in non alcoholic fatty liver disease: a possible marker of metabolic syndrome and early vascular damage 160
Iron and insulin resistance 159
NPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 159
Increased ferritin predicts vascular damage in patients with nonalcoholic fatty liver disease 158
Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis 157
A1-antitripsin mutations are associated with altered iron metabolism but not liver damage in non alcoholic fatty liver disease 156
Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients 156
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 156
Homozygosity for the PNPLA3/Adiponutrin I148m polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 155
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma 155
Prevalence and natural history of portal vein thrombosis, evaluated by contrast enhanced ultrasonography (CEUS), in patients with hepatocellular carcinoma 154
Iron status modulates the expression of the ubiquitin ligase mdm-2 and of its target p53 in mouse hepatocytes and primary human monocytes 154
Treatment choices for people infected with HCV 154
PNPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 152
Relationship between early vascular damage and physical exercise in patients with non alcoholic fatty liver disease 151
Portal hypertension and iron depletion in patients with genetic hemochromatosis 151
Hypermethylation of oncosuppressor genes in hereditary hemochromatosis 150
Risk of early atherosclerosis by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease and low visceral adiposity 150
MiRNA signature in NAFLD: A turning point for a non-invasive diagnosis 150
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels : a role for insulin resistance and diabetes 149
Increased prevalence of PIS Alpha1-antitrypsin allele in italian patients with non alcoholic fatty liver disease 149
PNPLA3/adiponutrin genotype is strongly associated with metabolic syndrome components and liver damage in patients with non-alcoholic fatty liver disease 148
Progression of carotic atherosclerotic damage is related to ALT values 148
Homozygosity for the PNPLA3/Adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 148
Relative contribution of iron genes, dysmetabolism and hcv in the pathogenesis of altered iron regulation in chronic hepatitis C 147
Totale 21.642
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.875
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.603 0 0 0 0 0 0 0 0 618 638 215 132
2020/20215.032 248 329 338 201 414 305 421 276 562 478 909 551
2021/20225.016 381 199 266 472 352 362 423 354 598 403 423 783
2022/20235.095 629 537 458 469 605 952 128 366 500 75 252 124
2023/20243.818 143 325 210 252 939 255 232 183 126 260 416 477
2024/20256.151 412 1.021 334 1.016 681 456 527 1.048 656 0 0 0
Totale 45.712